J Neurogastroenterol Motil  
Thailand Dyspepsia Guidelines: 2018
Rapat Pittayanon,1,2 Somchai Leelakusolvong,3* Ratha-Korn Vilaichone,2,4 Jarin Rojborwonwitaya,5 Sombat Treeprasertsuk,1 Pisaln Mairiang,6 Supphamat Chirnaksorn,7 Taned Chitapanarux,8 Uayporn Kaosombatwattana,3 Jaksin Sottisuporn,9 Inchaya Sansak,10 Pochamana Phisalprapa,3 Chalermrat Bunchorntavakul,11 Surapon Chuenrattanakul,12 Suriya Chakkaphak,13 Rattana Boonsirichan,14 Olarn Wiwattanachang,10 Monthira Maneerattanaporn,3 Wanich Piyanirun,12 and Varocha Mahachai1,2*
1Department of Medicine, Faculty of Medicine, Chulalongkorn University and KingChulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand; 2National GastricCancer and Gastrointestinal Diseases Research Center, Pathumthani, Thailand; 3Departmentof Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; 4Department of Medicine, Thammasat University Hospital, Pathum Thani, Thailand; 5Thonburi Hospital, Bangkok, Thailand; 6Department of Medicine, Faculty of Medicine,Khon Kaen University, Thailand; 7Department of Medicine, Ramathibodi Hospital, MahidolUniversity, Bangkok, Thailand; 8Department of Medicine, Faculty of Medicine, Chiang MaiUniversity, Thailand; 9NKC institute of Gastroenterology and Hepatology, SongklanagarindHosptial, Hat Yai, Songkhla, Thailand; 10Udonthani Hospital, Udon Thani, Thailand; 11Rajavithi Hospital, Bangkok, Thailand; 12Phramongkutklao Hospital, Bangkok, Thailand; 13Bumrungrad Hospital, Bangkok, Thailand; and 14Vachira Hospital, Bangkok, Thailand
Correspondence to: Somchai Leelakusolvong, MD
Siriraj Endoscopy Center, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Tel: +66-2-419-7281, Fax: +66-2-411-5013, E-mail: somchai.lee@mahidol.ac.th
Varocha Mahachai, MD
Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand
Tel: +66-2-256-4265, Fax: +66-2-256-4504, E-mail: vmahachai88@gmail.com
*Correspondence: Somchai Leelakusolvong and Varocha Mahachai are equally responsible for this study.
Received: May 10, 2018; Revised: July 23, 2018; Accepted: August 10, 2018; Published online: November 23, 2018.
© The Korean Society of Neurogastroenterology and Motility. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
The management of dyspepsia in limited-resource areas has not been established. In 2017, key opinion leaders throughout Thailand gathered to review and evaluate the current clinical evidence regarding dyspepsia and to develop consensus statements, rationales, levels of evidence, and grades of recommendation for dyspepsia management in daily clinical practice based on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. This guideline is mainly focused on the following four topics: (1) evaluation of patients with dyspepsia, (2) management, (3) special issues (overlapping gastroesophageal reflux disease/irritable bowel syndrome and non-steroidal anti-inflammatory drug/aspirin use), and (4) long-term follow-up and management to provide guidance for physicians in Thailand and other limited-resource areas managing such patients.
Keywords: Dyspepsia; Guideline; Thailand


This Article

e-submission

Archives

Aims and Scope